Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
November 9, 2017
Ignyta to Present at the Jefferies 2017 London Healthcare Conference
SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (RXDX), a biotechnology company focused on precision medicine in oncology, announced today that Jacob Chacko, M.D., its Chief Financial Officer, will make ...
November 9, 2017
STRATA Skin Sciences Reports Third Quarter 2017 Financial Results
HORSHAM, Pa., Nov. 09, 2017 (GLOBE NEWSWIRE) -- (SSKN) STRATA Skin Sciences, Inc. (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to ...
November 9, 2017
Altimmune Announces Third Quarter 2017 Financial Results and Provides Corporate Update
GAITHERSBURG, Md., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced financial results for the three- and nine-months ended ...
November 9, 2017
BioDelivery Sciences Reports Third Quarter 2017 Financial Results and Provides Corporate Update
RALEIGH, N.C., Nov. 9, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) today reported financial results for the three and nine months ended September 30, 2017, ...
November 9, 2017
BioTime Reports Third Quarter Results and Recent Corporate Accomplishments
ALAMEDA, Calif.--(BUSINESS WIRE)-- BioTime, Inc. (NYSE American: BTX), a late stage clinical biotechnology company developing and commercializing products addressing degenerative diseases, today reported financial results for ...
November 9, 2017
CorMedix Inc. Reports Third Quarter Financial Results and Provides Business Update
BERKELEY HEIGHTS, NJ / ACCESSWIRE / November 9, 2017 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products ...
November 9, 2017
CytoSorbents Continues Strong Trajectory of Growth in the Third Quarter 2017
MONMOUTH JUNCTION, N.J., Nov. 9, 2017 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader using blood purification to prevent or treat life-threatening injury and ...
November 8, 2017
VALNEVA Signs $39.6 Million IXIARO® Supply Contract with US Government
Valneva SE ("Valneva" or "the Company"),  a fully integrated, commercial stage biotech company focused on developing innovative, life-saving vaccines, announces today the signing of a ...
November 8, 2017
Kiadis Pharma Announces Participation at Three Upcoming Investor Events
Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing innovative products to make bone marrow ...
November 8, 2017
Kamada to Announce Third Quarter 2017 Financial Results and Host Conference Call on November 13
REHOVOT, Israel, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Kamada Ltd. (KMDA) (KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announced today that it ...
November 8, 2017
Sierra Oncology Reports Third Quarter Results
VANCOUVER , Nov. 8, 2017 /CNW/ - Sierra Oncology, Inc. (SRRA), a clinical stage drug development company focused on advancing next generation DNA Damage Response ...
November 8, 2017
Paratek Pharmaceuticals Reports Third Quarter 2017 Financial Results, Remains on Track to Complete NDA Submissions in First Quarter of 2018
BOSTON, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon ...
November 8, 2017
Ignyta Announces New Data Highlighting Immune Modulation of RXDX-106 at the Society for Immunotherapy of Cancer (SITC) Meeting
SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (RXDX), a biotechnology company focused on precision medicine in oncology, today announced new preclinical data for RXDX-106 – a novel immunomodulatory agent that ...
November 8, 2017
Imaging for Women Now Offering iCAD’s PowerLook® Tomo Detection for Digital Breast Tomosynthesis
KANSAS CITY, Mo., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Imaging for Women, a leading radiology center in Kansas City, Missouri, today announced that it is ...
November 8, 2017
Lipocine Announces Financial and Operational Results for the Third Quarter and Nine Months Ended September 30, 2017
SALT LAKE CITY, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Lipocine Inc. (LPCN), a specialty pharmaceutical company, today announced financial results for the three and nine ...
November 8, 2017
Intec Pharma, Ltd. to Present at the Jefferies 2017 London Healthcare Conference
JERUSALEM, November 8, 2017 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ, TASE: NTEC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion ...
November 8, 2017
UroGen Pharma to Host Third Quarter 2017 Financial Results Conference Call on Tuesday, November 14, 2017
RA’ANANA, Israel and NEW YORK, Nov. 08, 2017 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs ...
November 8, 2017
Rexahn Pharmaceuticals Doses First Patient in a Phase IIa Clinical Trial of RX-3117 in Combination with Abraxane® in Patients Newly Diagnosed with Metastatic Pancreatic Cancer
ROCKVILLE, Md., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE AMERICAN:RNN), today announced that it has dosed the first patient in a Phase ...
November 8, 2017
Minerva Neurosciences to Present at Jefferies 2017 London Healthcare Conference on November 15, 2017
WALTHAM, Mass., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...
November 8, 2017
Zealand Pharma: Interim report for the first nine months of 2017
Copenhagen, November 8, 2017 - Zealand Pharma A/S ("ZEAL") announces financial results and continued strong progress for its product candidates and business for the first ...
Page 100 of 138